Concepedia

68Ga-DOTA-Affibody molecule for in vivo assessment of HER2/neu expression with PET

Gabriela Krämer-Marek, Nalini Shenoy, Jürgen Seidel, Gary L. Griffiths, Peter L. Choyke, Jacek Capala

European Journal of Nuclear Medicine and Molecular Imaging · 2011 · 56 citations · 25 references

DOIFull text

Open access

Concepts

References

25

Resistance to Trastuzumab in Breast Cancer

Paula R. Pohlmann, Ingrid A. Mayer, Ray Mernaugh · Clinical Cancer Research · 2009 · 507 citations · Full text

, , +15

Molecular Imaging of <i>HER2</i>-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic <sup>111</sup>In- or <sup>68</sup>Ga-Labeled Affibody Molecules

Richard P. Baum, Vikas Prasad, Dirk Müller et al. · Journal of Nuclear Medicine · 2010 · 307 citations · Full text

, , +17

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

Peter Smith‐Jones, David B. Solit, Timothy Akhurst et al. · Nature Biotechnology · 2004 · 305 citations

, , +13

Comparison of HER-2 overexpression in primary breast cancer and metastatic sites and its effect on biological targeting therapy of metastatic disease

Jamal Zidan, Igor Dashkovsky, Celina Stayerman et al. · British Journal of Cancer · 2005 · 281 citations · Full text

, , +17

(68)Ga-labeled peptides in tumor imaging.

Helmut R. Maëcke, Michael Hofmann, Uwe Haberkorn · PubMed · 2005 · 243 citations

, , +17